Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Ethinyl Estradiol; Segesterone Acetate Patent Expiration

Ethinyl Estradiol; Segesterone Acetate is used for hormonal contraception. It was first introduced by Mayne Pharma Llc in its drug Annovera on Aug 10, 2018.


Ethinyl Estradiol; Segesterone Acetate Patents

Given below is the list of patents protecting Ethinyl Estradiol; Segesterone Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Annovera US10632066 Method of providing birth control Feb 01, 2039 Mayne Pharma
Annovera US10765628 Method of providing birth control Feb 01, 2039 Mayne Pharma
Annovera US10780047 Method of providing birth control Feb 01, 2039 Mayne Pharma
Annovera US10918649 System for providing birth control Jun 21, 2039 Mayne Pharma
Annovera US10925882 System for providing birth control Jun 21, 2039 Mayne Pharma
Annovera US10940157 System for providing birth control Jun 21, 2039 Mayne Pharma
Annovera US11529308 System for providing birth control Jun 21, 2039 Mayne Pharma
Annovera US11850251 System for providing birth control Jun 21, 2039 Mayne Pharma


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳